Selected Publications

  1. Leuchter AF, Cook IA, Marangell LB, Gilmer WS, Burgoyne KS, Howland RH, Trivedi MH, Zisook S, Jain R, McCracken JT, Fava M, Iosifescu D, Greenwald S: Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study. Psychiatry Research 2009; 169:124-131
  2. Leuchter AF, Cook IA, Gilmer WS, Marangell LB, Burgoyne KS, Howland RH, Trivedi MH, Zisook S, Jain R, Fava M, Iosifescu D, Greenwald S: Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in Major Depressive Disorder. Psychiatry Research 2009; 169:132-138
  3. Leuchter AF, Cook IA, Hamilton SP, Narr KL, Toga A, Hunter AM, Faull K, Whitelegge J, Andrew AM, Loo J, Way B, Nelson SF, Horvath S, Lebowitz BD: Biomarkers to predict antidepressant treatment response. Current Psychiatry Reports 2010;12:553–562
  4. Hunter AM, Cook IA, Leuchter AF: Impact of antidepressant treatment history on clinical outcomes in placebo and medication treatment of Major Depression. Journal of Clinical Psychopharmacology2010; 30(6):748-751
  5. Cook IA, Schrader LM, DeGiorgio CM, Miller PR, Maremont ER, Leuchter AF: Trigeminal nerve stimulation in major depressive disorder: acute outcomes in an open pilot study. Epilepsy & Behavior2013; 28:221-226
  6. Leuchter AF, Cook IA, Jin Y, Phillips B: The relationship between brain oscillatory activity and therapeutic effectiveness of transcranial magnetic stimulation in the treatment of major depressive disorder. Frontiers in Human Neuroscience 2013; 7(37)1-12
  7. Hunter AM, Korb AS, Cook IA, Leuchter AF: Rostral anterior cingulate activity in major depressive disorder: state or trait marker of responsiveness to medication? The Journal of Neuropsychiatry and Clinical Neurosciences 2013; 25(2):126-133
  8. Cook IA, Espinoza R, Leuchter AF: Neuromodulation for depression: invasive and noninvasive (deep brain stimulation, transcranial magnetic stimulation, trigeminal nerve stimulation).  Neurosurgery Clinics of North America 2014; 25:103–116
  9. Leuchter AF, Hunter AM, Tartter M, Cook IA: Role of pill-taking, expectation and therapeutic alliance in the placebo response in clinical trials for major depression. British Journal of Psychiatry 2014; 205(6):443-9
  10. Leuchter AF, Hunter AM, Krantz DE, Cook IA: Intermediate phenotypes and biomarkers of treatment outcome in major depressive disorder. Dialogues in Clinical Neuroscience 2014; 16(4):525-37
  11. McGough JJ, Loo SK, Sturm A, Cowen J, Leuchter AF, Cook IA: An eight-week, open-trial, pilot feasibility study of trigeminal nerve stimulation in youth with attention deficit/hyperactivity Brain Stimulation 2015; 8(2):299-304
  12. Leuchter AF, Hunter AM, Krantz, DE, Cook IA: Rhythms and blues: modulation of oscillatory synchrony and the mechanism of action of antidepressant treatments. Annals of the New York Academy of Sciences 2015; 1344:78-91
  13. Leuchter AF, Cook IA, Feifel D, Goethe JW, Husain M, Carpenter LL, Thase ME, Krystal AD, Philip NS, Bhati MT, Burke WJ, Howland RH, Sheline YI, Aaronson ST, Iosifescu DV, O’Reardon JP, Gilmer WS, Jain R, Burgoyne KS, Phillips B, Manberg PJ, Massaro J, Hunter AM, Lisanby SH, George MS: Efficacy and safety of low-field synchronized transcranial magnetic stimulation (sTMS) for treatment of major depression. Brain Stimulation 2015; 8(4):787-94
  14. Hunter AM, Cook IA, Tartter M, Sharma SK, Disse GD, Leuchter AF: Antidepressant treatment history and drug-placebo separation in a placebo-controlled trial in major depressive disorder. Psychopharmacology 2015; 232(20):3833-40